ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation

Qun Liu(Brookhaven National Laboratory), Jian Liu(University of Missouri Health System)
International Journal of Oncology
November 14, 2019
Cited by 33


Related Papers